Stay updated with breaking news from Device Exemption. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MedAlliance, the visionary Swiss-based medical technology company has announced the successful acquisition by Cordis, a transaction valued at USD 1.135 billion (Rs. ~ 10,000 Crores). Know details here.
- Presented positive 30-day follow-up results from the C-GUARDIANS U.S. Investigational Device Exemption clinical trial demonstrating an overall major adverse events rate of 0.95% from procedure...
TEL AVIV, Israel and MIAMI, Nov. 01, 2023 -- InspireMD, Inc. , developer of the CGuard™ Embolic Prevention Stent System for the prevention of stroke, today presented 30-day results from the...
Interim report January- September 2023 XVIVO Perfusion AB Interim report January-September 2023 ...
After an over decade-long discourse amongst interested stakeholders, on October 3, 2023, FDA unveiled its proposed rule and policy to increase oversight over LDTs.